The Development of New Stereoselective Organocatalytic Processes
新型立体选择性有机催化工艺的发展
基本信息
- 批准号:7526718
- 负责人:
- 金额:$ 28.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAcidsAddressAminesAreaAziridinesBiochemistryBiologicalBiological FactorsCarbonCatalysisChemical StructureChemistryCyclizationDNA Sequence RearrangementDevelopmentDrug DesignEstersEvaluationExhibitsGoalsHandednessHealthHumanHuman ResourcesHydrogen BondingImageImidesIminesIndolesInvestigationKetonesKineticsLeadLifeLiteratureMetalsMethodologyMethodsNatureNumbersOutcomePharmaceutical PreparationsPharmacologic SubstancePhosphoric AcidsPlayProceduresProcessProlinePublic HealthPublishingPyrrolesQualifyingReactionReportingResearchResolutionRouteSchemeStereoisomerSulfonamidesTestingWorkamidationaziridinebasecatalystchiral moleculecostdesignimidazoloneindoleinnovationinterestmethod developmentsmall moleculesuccessthree dimensional structure
项目摘要
DESCRIPTION (provided by applicant): Significant portions of important molecules involved in the biochemistry of life have "handedness," i.e. they are primarily found in one nonsuperimposible mirror image form. Additionally, the majority of drugs and drug candidates also have handedness (chirality) and all stereoisomers of these compounds are normally synthesized and evaluated for biological activity. Due to the chirality of nature, the mirror image forms of drug candidates can have vastly differing biological effects. One approach to the synthesis of chiral molecules that is growing steadily in usage is the application of versatile, stereoselective catalytic methodology in key steps where stereocontrol is required. Organocatalysis, the use of small organic (non-metal based) molecules as catalysts is an attractive alternative to traditional metal-based catalysis. This approach has found a number of recent successes and the continued evaluation of organocatalytic-based chemistry is clearly a worthwhile endeavor. Since 2004 the use of chiral phosphoric acid-based organocatalysis has been shown to provide for excellent stereoselectivity in a growing number of reactions. Our efforts have been involved in the development of new methodology where chiral phosphoric acids can be applied stereoselectively. The specific aims of this proposal are divided into the design, analysis, and refinement of a number of new reactions whereby chiral phosphoric acids can be efficient, stereoselective catalysts. The potential health-related utility of the newly created chiral products are also described in each new reaction study. PUBLIC HEALTH RELEVANCE: The chemistry described in this proposal addresses a fundamental, important aspect of modern synthesis -- the control of three-dimensional (3-D) chemical structure. The vast majority of the "molecules of life" and most pharmaceutical drugs have specific 3-D structure that must be controlled for efficient, low cost synthesis. Therefore methods that allow for this control are very important for public health.
描述(由申请人提供):生命生物化学涉及的重要分子的重要部分具有“交接性”,即它们主要以一种不耐用的镜像形式找到。此外,大多数药物和候选药物也具有惯用性(手性),并且这些化合物的所有立体异构体通常经过合成并评估生物学活性。由于大自然的手性,候选药物的镜像形式可能具有巨大不同的生物学作用。在使用中稳步生长的手性分子合成的一种方法是在需要立体控制的关键步骤中应用多功能的立体选择性催化方法。有机催化,将小有机(非金属)分子用作催化剂是传统金属催化的一种有吸引力的替代品。这种方法发现了许多最近的成功,基于器官的化学的持续评估显然是值得的。自2004年以来,使用手性磷酸的有机刻塔的使用可在越来越多的反应中提供出色的立体选择性。我们的努力参与了新方法的发展,在这些方法论中,手性磷酸可以立体选择应用。该提案的具体目的分为许多新反应的设计,分析和完善,从而有效地磷酸可以有效,立体选择性催化剂。每项新反应研究还描述了新创建的手性产品的潜在与健康相关的效用。公共卫生相关性:该提案中描述的化学涉及现代合成的基本,重要方面 - 对三维(3-D)化学结构的控制。绝大多数“生命分子”和大多数药物具有特定的3-D结构,必须控制高效,低成本的合成。因此,允许这种控制的方法对于公共卫生非常重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jon Antilla其他文献
Jon Antilla的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jon Antilla', 18)}}的其他基金
The Development of New Stereoselective Organocatalytic Processes
新型立体选择性有机催化工艺的发展
- 批准号:
8111917 - 财政年份:2008
- 资助金额:
$ 28.15万 - 项目类别:
The Development of New Stereoselective Organocatalytic Processes
新型立体选择性有机催化工艺的发展
- 批准号:
8299496 - 财政年份:2008
- 资助金额:
$ 28.15万 - 项目类别:
The Development of New Stereoselective Organocatalytic Processes
新型立体选择性有机催化工艺的发展
- 批准号:
7902255 - 财政年份:2008
- 资助金额:
$ 28.15万 - 项目类别:
The Development of New Stereoselective Organocatalytic Processes
新型立体选择性有机催化工艺的发展
- 批准号:
7682969 - 财政年份:2008
- 资助金额:
$ 28.15万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深层碳酸盐岩酸蚀裂缝中反应-非线性两相流界面演化机制研究
- 批准号:52304047
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
核苷酸代谢酶氧化修饰调控上皮干细胞命运在口腔白斑病光动力治疗复发中的机制与意义研究
- 批准号:82330029
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
RNF31通过厚壁菌代谢产物3-氧代胆碱酸调控RORγ信号轴抑制Th17细胞分化—溃疡性结肠炎干预新靶点
- 批准号:82360112
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Spatio-temporal mechanistic modeling of whole-cell tumor metabolism
全细胞肿瘤代谢的时空机制模型
- 批准号:
10645919 - 财政年份:2023
- 资助金额:
$ 28.15万 - 项目类别:
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 28.15万 - 项目类别:
Pharmacokinetics-Based DNA-Encoded Library Screening
基于药代动力学的 DNA 编码文库筛选
- 批准号:
10644211 - 财政年份:2023
- 资助金额:
$ 28.15万 - 项目类别:
Genome Instability Induced Anti-Tumor Immune Responses
基因组不稳定性诱导的抗肿瘤免疫反应
- 批准号:
10626281 - 财政年份:2023
- 资助金额:
$ 28.15万 - 项目类别: